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Abstract  
The use of transcranial direct current stimulation (tDCS) as a noninvasive therapeutic approach for 
Alzheimer’s disease (AD) has gained increasing attention. Research regarding the utility of tDCS in AD is 
inconsistent. In this study, we reviewed the importance of individual diversity among AD patients, starting 
with uninformative mean results. We also demonstrated variations among AD patients. Highly educated 
patients seemed to benefit more from therapy; education also seems to modulate baseline measurements 
and results. Individual cortical morphology also affects current distribution, which influences the 
effectiveness of stimulation. We suggest using structural MRI to distinguish inter-individual variability; 
high-resolution modeling may also be used to predict current distributions and should be combined with 
cognitive training (CT) and tDCS. 
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Introduction  
Alzheimer’s disease (AD) is a major form of age-related dementia and currently affects over 35 million 
people worldwide (http://www.alz.co.uk/research/world-report). It is associated with impaired episodic 
memory, as well as other cognitive abilities such as word retrieval, language comprehension, calculation, 
visuospatial orientation, learning capacity, abstract thinking and judgment [1]. Moreover, it induces 
changes in personality and disturbs mood [2]. Currently, there is no effective therapy for AD, and 
pharmacological treatments are associated with significant adverse effects [3]. The substantial costs and 
social burden of AD demand alternative or complementary and low-cost therapeutic treatments for this 
disease. In this context, non-pharmacological interventions have gained increasing attention in recent 
years. Such interventions include non-invasive brain stimulation techniques such as transcranial direct 
current stimulation (tDCS) and transcranial magnetic stimulation (TMS) [4], particularly in combination with 
cognitive training [5]. 
In tDCS, the current is passed through saline-soaked sponge electrodes on the scalp, penetrates the skull 
and influences neuronal function. Cathodal tDCS (ctDCS) suppresses cortical activity, anodal tDCS (atDCS) 
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has an activating effect, and sham current is used as a placebo [6]. As a type of non-invasive brain 
stimulation, tDCS helps to improve various cognitive functions, including motor activity [7], executive 
function and language ability [8]. Compared with rTMS, which is applied above the active threshold, tDCS 
modulates brain activity through low-intensity electrical currents (1 to 2 mA); tDCS also has fewer side 
effects and is less invasive, less expensive, easier to use, better controlled, and potentially portable [7]. 
Moreover, with respect to randomized, double-blinded trials, it is difficult to distinguish real tDCS from 
sham stimulation because of its subthreshold modulation. 
The mechanism of tDCS in AD may be related to brain-derived neurotrophic factor (BDNF). BDNF is 
required for the survival and synaptic growth of cells compromised by AD [9]; decreased BDNF levels are 
related to oligomeric amyloid, the major toxic species in AD [10], and correlate with neurodegeneration 
[11-13]. Decreased BDNF levels also cause defects in long-term potentiation and memory, which correlate 
with cognitive decline [14-16]. tDCS induces changes in the neuronal membrane resting threshold and 
contributes to plasticity changes [8]. These effects may occur via the BDNF gene [17]. 
The existing reviews of tDCS for AD have focused on study design, stimulus parameters and locations 
[3,8,18]. Notably, before these reviews, all of the studies regarding tDCS in AD have demonstrated its 
effect. Three additional studies regarding tDCS in AD were published after these reviews, but the results of 
these studies were inconsistent. Herein, we discuss variations observed among affected individuals, which 
may determine the effectiveness of tDCS in the treatment of AD. These variations include differences in the 
local structure of both grey and white matter, educational level and cortical morphology. Studying these 
factors may help us to better understand the scope of the application of tDCS and its limitations. 
Variability of individual response 
Mean results may be uninformative in behavioral experiments, particularly when the inclusion criteria 
for the subjects are based only on a cognitive neuropsychology test. Researchers typically focus on changes 
in the mean response associated with an experimental manipulation. However, this averaging ignores large 
variations in individual responses [19]. According to our screening data (Table 1) in which we used mean 
responses, the effects of tDCS in AD were mixed. Three studies observed a primary effect when they 
compared anodal and either cathodal or sham groups. Regarding these studies, one observed that atDCS 
significantly improved recognition memory. Cathodal tDCS significantly decreased word recognition 
accuracy, whereas sham tDCS did not affect word accuracy. Another study noted that atDCS significantly 
improved visual recognition memory compared with sham stimulation. Moreover, atDCS also improved 
visual recognition memory by 8.99 % from baseline, whereas sham stimulation decreased visual recognition 
memory by 2.62 % [20-22]. The remaining three studies with parallel-sham controlled designs did not 
observe these effects. In one study, tDCS did not significantly ameliorate memory performance compared 
with sham tDCS [5]. The other study found no significant differences in apathy after 1 and 2 weeks 
compared with baseline [23]. The last study found that tDCS improved cognitive function via both anodal 
and cathodal interventions [24]. We believe that the differences in individual responses are an important 
source of variation. Furthermore, these types of individual differences may be more obvious in older adults 
because individual differences in life experience and cognitive abilities increase with age [25]. These 
differences may be enhanced when parallel-sham controlled study designs are used [5,23,24], as presented 
in Table 1. 
MRI studies of the human brain have demonstrated inter-individual variability in a wide range of basic 
and higher cognitive functions, including perception, motor control, memory, aspects of consciousness and 
introspection. This variability may be predicted based on the local structure of grey and white matter, as 
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assessed by either voxel-based morphometry or diffusion tensor imaging [19]. Because tDCS is a 
neuromodulatory tool that influences neuronal function by applying current to specific neural structures, it 
is important to adequately consider inter-individual differences in the aspects described below. 
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(MMSE scores) 
The following variables were extracted from all studies when pertinent and available: (a) study design, (b) demographic variability of aging, including 
the number of participants, mean age, gender, and educational level, and (c) screening baseline and neuropsychological diagnosis. 
NINCDS-ADRDA: National Institute of Neurology and Communication Disorders and Stroke-The Alzheimer's Disease and Related Disorders 
Association Criteria; DSM-IV: Diagnostic and Statistical Manual–IV; ①: patients from Italy; ②: patients from Brazil; MMSE: Mini-Mental State 
Examination; AC: atDCS plus CT; PC: sham tDCS plus CT; AM: atDCS plus motor training.  -: no effect. 
Education 
Education may serve as an important reference point for differences in individual life experience. Older 
adults with higher education levels have benefited from tDCS stimulation during a working memory task, 
whereas individuals with lower education levels did not experience any benefits [26]. As presented in Table 
1, highly educated patients seem benefit more with tDCS [20-22]. One testable hypothesis for this 
difference is that highly educated patients employ a different strategy than less educated patients. This 
strategy may enable these highly educated patients to better recruit prefrontal cortex (PFC) structures 
during specifics tasks. Support for this interpretation comes from a recent neuroimaging study that 
reported greater PFC activation in expert pilots but not novice pilots performing a track-following task [27]. 
This finding highlights the need for CT to develop different strategies to better recruit the PFC; we 
recommend combining tDCS with CT, which we will discuss in more detail below. 
Effective stimulation and measurements are needed both at baseline and after treatment. The Mini-
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Mental Status Examination (MMSE), which is used in the majority of studies, is a commonly administered 
measure of global cognitive functioning that is thought to be sensitive to dementia [5,20-24,28]. Compared 
with the traditional cut-off score of 24 for highly educated individuals, a cut-off score of 27 or more 
generates better estimates among individuals of different ethnicities [29], as less educated and older 
individuals tend to receive lower scores [30,31], and among illiterate patients, as both atDCS and ctDCS 
facilitate improvements in MMSE scores compared with sham tDCS [24]. Therefore, educational level also 
modulates participant recruitment and outcome measures. To effectively compare results across studies, 
matching patients’ backgrounds, including their educations, is important. Moreover, it may also be useful 
to conduct an IQ test in addition to the MMSE. 
Neuropathological variables 
Another critical issue is individual differences in cortical morphology, which influence current flow 
distribution [32-34]. In AD, cortical atrophy, synaptic damage and ventricular enlargement [35] lead to 
changes in the volume of cerebrospinal fluid (CSF), which exhibits greater conductivity and therefore 
significantly alters current pathways [32]. The current parameters used in AD patients are based on models 
of healthy subjects and clinical trial outcomes, which ignore individual variations in cortical morphology 
[36]. Moreover, an individual model is supposed to predict current distribution, so that it may effectively 
modulate the target area. 
The first modeling study used a CAD-rendered current flow distribution in the cortex of both healthy and 
stroke subjects [33]. Follow-up studies considered skull anisotropy, white matter, and gyri resolution and 
demonstrated the importance of anatomical influences on current flow [37,38]. Nevertheless, these models 
are often not utilized, most likely because they are difficult to compute. Among the studies of tDCS in AD 
patients that did not use the modeling approach, Halko et al. observed significant correlations between 
region-specific fMRI signals and the locations of stimulating electrodes, which were placed based on 
individualized MRI head models [39]. For individual models to be routinely used in tDCS studies, they must 
be easy to derive, and researchers must understand the importance of accurate head models for the 
determination of current flow and distribution in each patient. This understanding will naturally lead to 
more studies that may be compared. To better promote individual models, more studies are needed in 
which predicted current flow distributions are compared with outcomes. This type of model also offers the 
possibility of reaching deeper structures such as the hippocampus. 
Combining tDCS with cognitive training 
Given the increasing use of CT in AD, combining tDCS with CT may be even more beneficial. The term 
"cognitive training" is based on the use of structured methods rather than unspecific and freely managed 
approaches. The choice of approach depends on the study’s purpose. CT may be divided into two basic 
categories as follows: compensatory and restorative [40,41]. Compensatory strategies aim to teach new 
ways of performing cognitive tasks by working around cognitive deficits. Restorative strategies attempt to 
improve functioning in specific domains, with the ultimate goal of returning function in these domains to 
premorbid levels. Both strategies apply equally well to AD. To ameliorate memory impairment in AD and 
improve recall, the compensatory approach may involve taking relevant notes, and the restorative 
approach may involve repeated cuing and questioning [42]. 
In a study of mild to moderate AD patients, patients were randomly assigned to one of the following 
three study groups: anodal tDCS+individualized computerized (IC) memory training, sham tDCS+IC memory 
training, and anodal tDCS+motor training. tDCS was then administered during memory training of face–
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name associations (a type of CT). There was general improvement in IC memory performance in both the 
anodal and sham groups after 2 weeks; this effect was still significant after 12 weeks in the sham group [5]. 
A case study compared tDCS+CT with sham+CT in individuals with mild AD for 2 months. The results 
revealed that the combination of tDCS+CT had limited effects but stabilized patients’ global cognitive 
function for approximately 3 months and therefore slowed their cognitive decline [28]. Only two studies 
have combined tDCS with CT; one was a case study, a form of preliminary research. More studies are 
needed to determine the optimal combination of these two therapies, particularly with respect to the order 
and timing of the therapies. 
These two studies used different orders of stimulation; one used tDCS before CT [28], and the other 
used tDCS during CT [5]. Older subjects seem to be more sensitive to time course differences compared 
with younger subjects. One of the studies demonstrated that stimulation before and during the task in 
young individual exerted equivalent effects, but improvement in picture naming was observed only in the 
elderly if tDCS was administered during the task [43]. Anodal stimulation during the task may mediate 
activity-dependent calcium influx and therefore influence task-related plasticity, whereas anodal 
stimulation before the task may negate task-related plasticity [44]. Nonetheless, these studies are a useful 
reference for future studies of different CT tasks. 
Conclusion 
  Due to growing evidence that tDCS is a promising neurostimulation tool for rehabilitation, tDCS has 
been used in many studies. However, in studies of tDCS in AD, there has been a wide range of inter-
individual variability, including the education level of older adults; the mean results of behavioral 
evaluations may be insufficient to prove its effect. Additionally, individual differences in brain anatomy are 
extensive; these differences are increased in AD due to the course of the disease and also result in different 
cognitive disorders in different patients. MRI imaging of the brain is needed to understand individual 
differences before treatment to apply a precise dosage to the appropriate target region to optimize current 
flow. Future research should analyze individual baselines and responses and use randomized block designs 
to explore its different levels. Briefly, as an age-related disease among older adults, AD is suitable for the 
use of non-invasive tools with relatively small side effects such as tDCS, particularly in combination with CT. 
Additionally, because it enables flexible dosing, is inexpensive and is well tolerated, we recommend that 
structural MRI be combined with behavioral data to improve and optimize the effects of tDCS. 
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